NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-064-2001-0-US-01 Parallel Measurements of Multiple RNA, Proteins And Antibody Binding Using CryoArray US 60/316,544 Abandoned
NIMH E-247-2001-0-US-01 Effect of BDNF Genotype on verbal Memory And Risk For Schizophrenia US 60/316,736 Abandoned
NCI E-188-1996-0-AU-10 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME AU DIV 65575/01 Abandoned
NCI E-302-2000-2-CA-03 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanomas CA National Stage 2419567 Abandoned
NCI E-236-2001-0-US-01 New Adenovirus Type 7 Vectors US 60/316,361 Abandoned
NCI E-124-1996-0-US-04 FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE I AND RELATED COMPOSITIONS AND METHODS US DIV 09/942,858 6608181 Expired PDF
NCI E-117-1996-0-AU-06 VECTORS FOR DELIVERING VIRAL AND ONCOGENIC INHIBITORS AU National Stage 65499/01 Abandoned
NIDCR E-044-1998-0-US-03 Methods of Treating Chronic Pain US National Stage 09/787,660 6596269 Expired PDF
NCI E-198-2001-0-US-01 Use of a Histone Deacetylase Inhibitor to Increase The Entry of an Adenoviral Agent Into a Cell US 60/315,008 Abandoned
NICHD E-259-2000-0-US-02 Protein Kinase A and Carney Complex US ORD 09/935,916 6759525 Expired PDF
NIDCR E-219-1998-0-US-03 Artificial Salivary Gland US CON 09/938,706 6743626 Abandoned PDF
NIDCR E-320-2001-0-US-01 A Composition And Method For Inhibting Angiogenesis And Cell Proliferation US 60/314,561 Abandoned
NCI E-150-2001-0-US-01 Use of a Promotor of T-Cell Expansion And an Inducer of CD40 Stimulation in The Treatment or Prevention of a Pathologic State US 60/314,342 Abandoned
NIDDK E-242-2001-0-US-01 Stable Monomer of The HIV-1 Protease And Methods of Their Use US 60/314,388 Abandoned
NCI E-262-2000-0-US-03 SH2 Domain Binding Inhibitors US National Stage 10/362,231 6977241 Abandoned PDF
NCI E-262-2000-0-PCT-02 SH2 Domain Binding Inhibitors PCT PCT PCT/US01/26078 Expired
NCI E-262-2000-0-EP-06 SH2 Domain Binding Inhibitors EP National Stage 01964256.0 Abandoned
CC E-239-2001-1-US-01 Vessel Surface Reconstruction With A Tubular Deformable Model US ORD 09/934,968 Abandoned
NCI E-086-2001-0-US-01 Peptides of a Melanoma Antigen and their Use in Diagnostic, Prophylactic and Therapeutic Methods US 60/314,183 Abandoned
NCI E-262-2000-0-AU-04 SH2 Domain Binding Inhibitors AU National Stage 2001285133 Abandoned
NCI E-262-2000-0-CA-05 SH2 Domain Binding Inhibitors CA National Stage 2419870 Abandoned
NIAID E-246-2001-0-US-04 Immunization For Ebola Virus Infection US National Stage 09/913,909 6852324 Expired PDF
NCI E-123-2000-0-PCT-02 Method of Treating Cutaneous T-Cell Lymphoma By Administering A Histone Deacetylase Inhibitor PCT PCT PCT/US01/25827 Abandoned
NCI E-206-1995-3-US-10 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY` US DIV 09/931,700 7101548 Expired PDF
NCI E-317-2002-0-US-01 Molecular Characteristics of Non-Small Cell Lung Cancer US 60/312,400 Abandoned
NIAAA E-061-1998-0-US-04 Polymorphic Human Gabaa Receptor Alpha-6 Subunit US National Stage 09/930,589 6762294 Abandoned PDF
NIAAA E-321-2001-0-US-01 Novel Vasoconstrictor Cannabinoid Analogs US 60/312,674 Abandoned
NCI E-177-2000-1-CA-03 ENHANCED HOMOLOGOUS RECOMBINATION MEDIATED BY LAMBDA RECOMBINATION PROTEINS CA National Stage 2419322 Expired
NCI E-177-2000-1-IT-12 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins IT EP 01962178.8 Expired
NCI E-177-2000-1-CH-06 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins CH EP 01962178.8 Expired
NCI E-177-2000-1-SE-13 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins SE EP 01962178.8 Expired
NCI E-177-2000-1-GB-11 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins GB EP 01962178.8 Expired
NCI E-177-2000-1-ES-09 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins ES EP 01962178.8 Expired
NCI E-177-2000-1-DK-08 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins DK EP 01962178.8 Expired
NCI E-177-2000-1-FR-10 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins FR EP 01962178.8 Expired
NCI E-177-2000-1-EP-02 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins EP National Stage 01962178.8 Expired
NCI E-177-2000-1-DE-07 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins DE EP 01962178.8 Expired
NIAID E-275-2000-3-JP-04 Modifications of HIV ENV,GAG, And POL Enhance Immunogenicity For Genetic Immunization JP National Stage 2002-536324 Abandoned
NIAID E-275-2000-3-CA-02 Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunization CA National Stage 2419822 Abandoned
NCI E-177-2000-1-AU-04 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins AU National Stage 2001283377 Expired
NIAID E-275-2000-3-AU-05 Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity AU National Stage 2001284999 Abandoned
NCI E-194-1994-2-US-03 SUBSTITUTED O6-BENZYLGUANINES AND 6(4) - BENZYLOXPYRIMIDINES US DIV 09/928,410 6436945 Abandoned PDF
NCI E-177-2000-1-PCT-01 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins PCT PCT COMB PCT/US2001/025507 Expired
NIAID E-275-2000-3-PCT-01 Modifications Of HIV, ENV, GAG Enhance Immunogenicity For Genetic Immunization PCT PCT COMB PCT/US01/025721 Expired
NIAID E-275-2000-3-EP-09 Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunizations EP DIV 10011764.7 Abandoned
NIAID E-275-2000-3-EP-08 Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunizations EP DIV 9000424.3 Abandoned
NIAID E-275-2000-3-EP-03 Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunizations EP National Stage 01964108.3 Abandoned
NCI E-177-2000-1-EP-05 Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins EP DIV 10184430.6 Abandoned
NIEHS E-139-2000-0-AU-07 Use of Transgene Encoding a Vertebrate Phytase to Increase Capacity to Utilize Phytic Acid in Livestock Feed AU National Stage 2001281262 Abandoned
NIEHS E-139-2000-0-PCT-02 Use of Endogenous Vertebrate Phytase to Increase Capacity to Utilize Phytic Acid in Livestock Feed PCT PCT PCT/US01/25339 Expired